BRODNAX BRETT 4
Research Summary
AI-generated summary
Lumexa (LMRI) Director Brett Brodnax Receives RSU Award
What Happened
- Brett Brodnax, a director of Lumexa Imaging Holdings, Inc. (LMRI), received a grant of 19,358 restricted stock units (RSUs) on 2026-06-10. The reported acquisition price is $0.00 (award), so no cash changed hands at grant. The RSUs represent the contingent right to receive one share of common stock per RSU upon vesting.
Key Details
- Transaction date: 2026-06-10; Form 4 filed 2026-06-12 (within the typical two-business-day reporting window).
- Grant: 19,358 RSUs at $0.00 per unit (reported value $0 on the Form 4).
- Vesting: RSUs vest on the earlier of the one-year anniversary of the grant and the next annual meeting of stockholders, subject to Brodnax’s continued service (per footnote).
- Post-transaction holdings: not disclosed in the provided filing excerpt.
- Transaction type: Award/Grant (code A) — not a market purchase or sale.
Context
- RSUs are contingent compensation: they only convert to shares upon vesting and are not immediately tradable. Awards like this are common director compensation and do not by themselves indicate immediate buying or selling intent.
- Because this is a grant (not a purchase or sale), it’s informational about compensation rather than a direct bullish or bearish insider trade signal.